Free Trial

CME Group Inc. (NASDAQ:CME) Shares Bought by Asset Management One Co. Ltd.

CME Group logo with Finance background

Asset Management One Co. Ltd. lifted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 213,013 shares of the financial services provider's stock after purchasing an additional 5,284 shares during the period. Asset Management One Co. Ltd. owned 0.06% of CME Group worth $56,510,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Norges Bank purchased a new stake in shares of CME Group in the 4th quarter valued at approximately $1,107,389,000. Price T Rowe Associates Inc. MD grew its position in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares during the period. Raymond James Financial Inc. purchased a new position in CME Group in the fourth quarter worth approximately $871,063,000. GAMMA Investing LLC increased its stake in CME Group by 32,941.0% during the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock worth $493,144,000 after acquiring an additional 1,853,261 shares during the last quarter. Finally, Capital Wealth Planning LLC raised its position in CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock valued at $565,671,000 after purchasing an additional 996,498 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 0.6%

NASDAQ:CME traded up $1.65 during mid-day trading on Wednesday, hitting $273.03. The stock had a trading volume of 1,586,978 shares, compared to its average volume of 2,226,513. CME Group Inc. has a twelve month low of $192.11 and a twelve month high of $290.79. The stock has a 50-day simple moving average of $274.52 and a two-hundred day simple moving average of $255.92. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $98.39 billion, a PE ratio of 27.47, a PEG ratio of 3.70 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% on a year-over-year basis. During the same period last year, the business earned $2.50 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio (DPR) is 50.30%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CME. Keefe, Bruyette & Woods raised their price objective on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Morgan Stanley upped their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Piper Sandler lifted their target price on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat, CME Group currently has a consensus rating of "Hold" and a consensus target price of $258.20.

Read Our Latest Stock Analysis on CME Group

Insider Buying and Selling

In other CME Group news, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director now directly owns 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the transaction, the director now directly owns 2,915 shares in the company, valued at approximately $790,781.20. This represents a 25.54% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,400 shares of company stock worth $3,680,610 over the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines